Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.
BACKGROUND: Cytomegalovirus infection in renal transplant recipients is a major clinical problem, with both short and long term sequelae. Infection can occur as a result of reactivation of latent virus or new infection from donor tissues. The impact of donor and recipient serostatus on viremia is w...
Автори: | Hughes, D, Hafferty, J, Fulton, L, Friend, P, Devaney, A, Loke, J, Welsh, K, Handa, A, Klenerman, P |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2008
|
Схожі ресурси
Схожі ресурси
-
How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
за авторством: Mohammad Vaezi, та інші
Опубліковано: (2016-10-01) -
CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays
за авторством: Castro Ana, та інші
Опубліковано: (2001-05-01) -
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients
за авторством: Jumpei Hasegawa, та інші
Опубліковано: (2017-12-01) -
QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection
за авторством: Paolo Solidoro, та інші
Опубліковано: (2024-08-01) -
Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
за авторством: Reddy, S, та інші
Опубліковано: (2003)